UK delivery available • Pembrokeshire collection • Research use only

Alluvi Glow GHK-Cu Research Pen

GHK-Cu, BPC-157 and TB-500 formulation • Laboratory use only

Alluvi Glow GHK-Cu, BPC-157 and TB-500 research pen

Alluvi Glow product overview

Alluvi Glow is a fixed research formulation combining GHK-Cu, BPC-157 and TB-500 in two sealed, pre-filled research devices. It is supplied for controlled laboratory evaluation of peptide-blend compatibility, formulation stability, delivery format and handling characteristics.

The page below explains the contents of the formulation, why each component is of research interest and how the product should be stored and handled.

What is included?

Each Glow Research Kit contains two pre-filled research pens.

Each pen contains 5mg BPC-157, 5mg TB-500 and 25mg GHK-Cu.

Why is Glow studied?

Glow combines three compounds that are commonly discussed in laboratory research involving peptide signalling, formulation science and biological pathway investigation. Researchers may evaluate the combined formulation to study stability, compatibility and the behaviour of multiple compounds within one fixed delivery format.

Common areas of laboratory interest

What each component is studied for

GHK-Cu

GHK-Cu is a naturally occurring copper-binding peptide. In laboratory research, it is investigated in relation to copper-peptide signalling, extracellular-matrix pathways, collagen-related research models, gene expression and formulation behaviour.

Read the full GHK-Cu research guide.

BPC-157

BPC-157 is a synthetic research peptide studied in pre-clinical settings. Areas of investigation include peptide signalling, tissue models, gastrointestinal research models, angiogenesis pathways and compound stability.

Read the full BPC-157 research guide.

TB-500

TB-500 is a research compound associated with thymosin beta-4-related laboratory investigation. Research interests include actin regulation, cell migration, tissue models, peptide interaction and formulation science.

Read the full TB-500 research guide.

How the combined formulation may be evaluated

Researchers may use a combined formulation to examine whether the compounds remain stable when stored together, how they behave within a fixed-volume delivery device and whether the blend presents any measurable formulation or handling differences compared with individual compounds.

Typical controlled evaluations may include visual inspection, temperature stability, analytical verification, compatibility assessment and documentation of handling characteristics.

Reported research interests

The following topics describe areas in which the individual compounds or related pathways are commonly discussed in scientific research. They are not claims of treatment, clinical effectiveness or suitability for personal use.

Storage and handling

Keep the product refrigerated between 2°C and 8°C. Retain it in the original sealed packaging until required for controlled laboratory evaluation. Do not freeze.

Handle only under suitable laboratory procedures, with appropriate documentation, temperature control and research protocols.

Frequently asked questions

What does the Glow research pen contain?

The kit contains a total of 10mg BPC-157, 10mg TB-500 and 50mg GHK-Cu across two pre-filled research devices.

What is the formulation supplied for?

It is supplied for controlled laboratory research involving formulation stability, compound compatibility, delivery-format analysis and research handling evaluation.

Is Glow intended for human or veterinary use?

No. It is sold strictly for research and development purposes only and is not intended for human or veterinary use.

How should it be stored?

Store refrigerated between 2°C and 8°C. Do not freeze.

Are analytical reports available?

Available documentation can be viewed on the Laboratory Reports and COAs page.

Related research guides

Enquire via WhatsApp View Lab Reports Back to Products

Research-use disclaimer

All products supplied by Pembrokeshire Research Solutions are sold strictly for research and development purposes only.

They are not medicines, are not intended for human or veterinary use and must be handled only within appropriate research environments.

The research topics listed on this page describe areas of scientific investigation and should not be interpreted as medical advice, treatment guidance or claims of clinical benefit.